Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: A 3-year population-based longitudinal study
Corresponding Author
Daniel Feingold PhD
Psychology Department, Ariel University, Ariel, Israel
Lev-Hasharon Medical Center, Pardesiya, Israel
Correspondence
Daniel Feingold, Lev-Hasharon Medical Center, Pardesiya, Israel.
Email: [email protected]
Search for more papers by this authorJürgen Rehm PhD
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
Klinische Psychologie & Psychotherapie, Technische Universität Dresden, Dresden, Germany
Search for more papers by this authorHagai Factor MA
Masters Program, Psychology Department, Ariel University, Ariel, Israel
Search for more papers by this authorAvigayil Redler MA
Masters Program, Psychology Department, Ariel University, Ariel, Israel
Search for more papers by this authorShaul Lev-Ran MD
Lev-Hasharon Medical Center, Pardesiya, Israel
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for more papers by this authorCorresponding Author
Daniel Feingold PhD
Psychology Department, Ariel University, Ariel, Israel
Lev-Hasharon Medical Center, Pardesiya, Israel
Correspondence
Daniel Feingold, Lev-Hasharon Medical Center, Pardesiya, Israel.
Email: [email protected]
Search for more papers by this authorJürgen Rehm PhD
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
Klinische Psychologie & Psychotherapie, Technische Universität Dresden, Dresden, Germany
Search for more papers by this authorHagai Factor MA
Masters Program, Psychology Department, Ariel University, Ariel, Israel
Search for more papers by this authorAvigayil Redler MA
Masters Program, Psychology Department, Ariel University, Ariel, Israel
Search for more papers by this authorShaul Lev-Ran MD
Lev-Hasharon Medical Center, Pardesiya, Israel
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for more papers by this authorAbstract
Background
Cannabis use has been reported to negatively affect the course and outcome of various psychiatric disorders, yet little is known on its effect on rates of remission from anxiety disorders and associated clinical and functional outcomes.
Methods
In this study, data were drawn from Waves 1 and 2 of the National Epidemiologic survey on Alcohol and Related Conditions, focusing on individuals who qualified for a diagnosis of any anxiety disorder (social anxiety, panic disorder, generalized anxiety disorder, and specific phobias) at Wave 1 (N = 3,723). Cannabis users and individuals with cannabis use disorders (CUDs) throughout a 4-year period were compared to nonusers in rates of remission, suicidality, general functioning, and quality of life at Wave 2, while controlling for baseline confounders.
Results
Although rates of remission decreased with level of cannabis use, this was not maintained in adjusted models. Aside from specific outcomes (individuals with CUDs were significantly more prone to report breaking up from a romantic relationship; adjusted odds ratio [AOR] = 3.85, 95% confidence interval [CI] = 1.66–8.97) and repeatedly quitting school (AOR = 6.02, 95% CI = 2.65–13.66)), following adjustment no additional differences were found in outcome measures.
Conclusions
These findings add to previous reports suggesting that poorer outcome of anxiety disorders among cannabis users may be attributed mainly to differences in baseline factors and not cannabis use.
CONFLICT OF INTEREST
All authors declare that they have no conflicts of interest.
REFERENCES
- Agrawal, A., Nurnberger, J. I., Jr., & Lynskey, M. T. (2011). Cannabis involvement in individuals with bipolar disorder. Psychiatry Research, 185(3), 459–461. https://doi.org/10.1016/j.psychres.2010.07.007
- American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: Text revision (DSM-IV-TR) ( 4th ed.). Washington, DC: American Psychiatric Association.
10.1176/appi.books.9780890423349 Google Scholar
- Aspis, I., Feingold, D., Weiser, M., Rehm, J., Shoval, G., & Lev-Ran, S. (2015). Cannabis use and mental health-related quality of life among individuals with depressive disorders. Psychiatry Research, 230(2), 341–349. https://doi.org/10.1016/j.psychres.2015.09.014
- Bar-Haim, Y., Lamy, D., Pergamin, L., Bakermans-Kranenburg, M. J., & van, I. M. H. (2007). Threat-related attentional bias in anxious and nonanxious individuals: A meta-analytic study. Psychological Bulletin, 133(1), 1–24. https://doi.org/10.1037/0033-2909.133.1.1
- Bland, J. M., & Altman, D. G. (1995). Multiple significance tests: The Bonferroni method. BMJ (Clinical Research Ed.), 310(6973), 170.
- Borges, G., Bagge, C. L., & Orozco, R. (2016). A literature review and meta-analyses of cannabis use and suicidality. Journal of Affective Disorders, 195, 63–74. https://doi.org/10.1016/j.jad.2016.02.007
- Broyd, S. J., van Hell, H. H., Beale, C., Yucel, M., & Solowij, N. (2016). Acute and chronic effects of cannabinoids on human cognition—A systematic review. Biological Psychiatry, 79(7), 557–567. https://doi.org/10.1016/j.biopsych.2015.12.002
- Buckner, J. D., Heimberg, R. G., Ecker, A. H., & Vinci, C. (2013). A biopsychosocial model of social anxiety and substance use. Depression and Anxiety, 30(3), 276–284. https://doi.org/10.1002/da.22032
- Buckner, J. D., Heimberg, R. G., Matthews, R. A., & Silgado, J. (2012). Marijuana-related problems and social anxiety: The role of marijuana behaviors in social situations. Psychology of Addictive Behaviors, 26(1), 151–156. https://doi.org/10.1037/a0025822
- Buckner, J. D., Heimberg, R. G., & Schmidt, N. B. (2011). Social anxiety and marijuana-related problems: The role of social avoidance. Addictive Behaviors, 36(1-2), 129–132. https://doi.org/10.1016/j.addbeh.2010.08.015
- Buckner, J. D., Leen-Feldner, E. W., Zvolensky, M. J., & Schmidt, N. B. (2009). The interactive effect of anxiety sensitivity and frequency of marijuana use in terms of anxious responding to bodily sensations among youth. Psychiatry Research, 166(2-3), 238–246. https://doi.org/10.1016/j.psychres.2008.01.009
- Buckner, J. D., & Schmidt, N. B. (2009). Social anxiety disorder and marijuana use problems: The mediating role of marijuana effect expectancies. Depression and Anxiety, 26(9), 864–870. https://doi.org/10.1002/da.20567
- Buckner, J. D., Zvolensky, M. J., & Schmidt, N. B. (2012). Cannabis-related impairment and social anxiety: The roles of gender and cannabis use motives. Addictive Behaviors, 37(11), 1294–1297. https://doi.org/10.1016/j.addbeh.2012.06.013
- Carvalho, A. F., & Van Bockstaele, E. J. (2012). Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 38(1), 59–67. https://doi.org/10.1016/j.pnpbp.2012.01.008
- Chassin, L., Dmitrieva, J., Modecki, K., Steinberg, L., Cauffman, E., Piquero, A. R., … Losoya, S. H. (2010). Does adolescent alcohol and marijuana use predict suppressed growth in psychosocial maturity among male juvenile offenders? Psychology of Addictive Behaviors, 24(1), 48–60. https://doi.org/10.1037/a0017692
- Chatterji, S., Saunders, J. B., Vrasti, R., Grant, B. F., Hasin, D., & Mager, D. (1997). Reliability of the alcohol and drug modules of the Alcohol Use Disorder and Associated Disabilities Interview Schedule–Alcohol/Drug-Revised (AUDADIS-ADR): An international comparison. Drug and Alcohol Dependence, 47(3), 171–185.
- Cottler, L. B., Grant, B. F., Blaine, J., Mavreas, V., Pull, C., Hasin, D., … Mager, D. (1997). Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug and Alcohol Dependence, 47(3), 195–205.
- D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y. T., … Krystal, J. H. (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology, 29(8), 1558–1572. https://doi.org/10.1038/sj.npp.1300496
- Degenhardt, L., Coffey, C., Romaniuk, H., Swift, W., Carlin, J. B., Hall, W. D., & Patton, G. C. (2013). The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction, 108(1), 124–133. https://doi.org/10.1111/j.1360-0443.2012.04015.x
- Degenhardt, L., Hall, W., & Lynskey, M. (2001). The relationship between cannabis use, depression and anxiety among Australian adults: Findings from the National Survey of Mental Health and Well-Being. Social Psychiatry and Psychiatric Epidemiology, 36(5), 219–227.
- Douglas, K. R., Chan, G., Gelernter, J., Arias, A. J., Anton, R. F., Weiss, R. D., … Kranzler, H. R. (2010). Adverse childhood events as risk factors for substance dependence: Partial mediation by mood and anxiety disorders. Addictive Behaviors, 35(1), 7–13. https://doi.org/10.1016/j.addbeh.2009.07.004
- Eack, S. M., & Newhill, C. E. (2007). Psychiatric symptoms and quality of life in schizophrenia: A meta-analysis. Schizophrenia Bulletin, 33(5), 1225–1237. https://doi.org/10.1093/schbul/sbl071
- Elhai, J. D., Contractor, A. A., Biehn, T. L., Allen, J. G., Oldham, J., Ford, J. D., … Frueh, B. C. (2013). Changes in the Beck Depression Inventory-II's underlying symptom structure over 1 month of inpatient treatment. Journal of Nervous and Mental Disease, 201(5), 371–376. https://doi.org/10.1097/NMD.0b013e31828e1004
- ElSohly, M. A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., & Church, J. C. (2016). Changes in cannabis potency over the last 2 decades (1995-2014): Analysis of current data in the United States. Biological Psychiatry, 79(7), 613–619. https://doi.org/10.1016/j.biopsych.2016.01.004
- Essau, C. A., Conradt, J., & Petermann, F. (2002). Course and outcome of anxiety disorders in adolescents. Journal of Anxiety Disorders, 16(1), 67–81.
- Etkin, A., & Wager, T. D. (2007). Functional neuroimaging of anxiety: A meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. American Journal of Psychiatry, 164(10), 1476–1488. https://doi.org/10.1176/appi.ajp.2007.07030504
- Feingold, D., Weiser, M., Rehm, J., & Lev-Ran, S. (2016). The association between cannabis use and anxiety disorders: Results from a population-based representative sample. European Neuropsychopharmacology, 26(3), 493–505. https://doi.org/10.1016/j.euroneuro.2015.12.037
- Florea, I., Danchenko, N., Brignone, M., Loft, H., Rive, B., & Abetz-Webb, L. (2015). The effect of vortioxetine on health-related quality of life in patients with major depressive disorder. Clinical Therapeutics, 37(10), 2309–2323.e6. https://doi.org/10.1016/j.clinthera.2015.08.008
- Foti, D. J., Kotov, R., Guey, L. T., & Bromet, E. J. (2010). Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. American Journal of Psychiatry, 167(8), 987–993. https://doi.org/10.1176/appi.ajp.2010.09020189
- Friedman, M. J., Resick, P. A., Bryant, R. A., Strain, J., Horowitz, M., & Spiegel, D. (2011). Classification of trauma and stressor-related disorders in DSM-5. Depression and Anxiety, 28(9), 737–749. https://doi.org/10.1002/da.20845
- Gage, S. H., Hickman, M., Heron, J., Munafo, M. R., Lewis, G., Macleod, J., & Zammit, S. (2015). Associations of cannabis and cigarette use with depression and anxiety at age 18: Findings from the Avon Longitudinal Study of Parents and Children. PLoS One, 10(4), e0122896. https://doi.org/10.1371/journal.pone.0122896
- Gibbs, M., Winsper, C., Marwaha, S., Gilbert, E., Broome, M., & Singh, S. P. (2014). Cannabis use and mania symptoms: A systematic review and meta-analysis. Journal of Affective Disorders, 171, 39–47. https://doi.org/10.1016/j.jad.2014.09.016
- Grant, B. F., Chou, S. P., Goldstein, R. B., Huang, B., Stinson, F. S., Saha, T. D., … Ruan, W. J. (2008). Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: Results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 69(4), 533–545.
- Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, P. S., Kay, W., & Pickering, R. (2003). The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): Reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug and Alcohol Dependence, 71(1), 7–16.
- Grant, B. F., & Kaplan, K. (2005). Source and accuracy statement for the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.
- Grant, B. F., Moore, T. C., Shepard, J., & Kaplan, K. (2003). Source and accuracy statement: Wave 1 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism.
- Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., … Kaplan, K. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61(8), 807–816. https://doi.org/10.1001/archpsyc.61.8.807
- Grech, A., Van Os, J., Jones, P. B., Lewis, S. W., & Murray, R. M. (2005). Cannabis use and outcome of recent onset psychosis. European Psychiatry, 20(4), 349–353. https://doi.org/10.1016/j.eurpsy.2004.09.013
- Grucza, R. A., Abbacchi, A. M., Przybeck, T. R., & Gfroerer, J. C. (2007). Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys. Addiction, 102(4), 623–629. https://doi.org/10.1111/j.1360-0443.2007.01745.x
- Grunberg, V. A., Cordova, K. A., Bidwell, L. C., & Ito, T. A. (2015). Can marijuana make it better? Prospective effects of marijuana and temperament on risk for anxiety and depression. Psychology of Addictive Behaviors, 29(3), 590–602. https://doi.org/10.1037/adb0000109
- Hall, W. (2015). What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction, 110(1), 19–35. https://doi.org/10.1111/add.12703
- Hasin, D., Van Rossem, R., McCloud, S., & Endicott, J. (1997). Alcohol dependence and abuse diagnoses: Validity in community sample heavy drinkers. Alcoholism, Clinical and Experimental Research, 21(2), 213–219.
- Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., … Grant, B. F. (2015). Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiatry, 72(12), 1235–1242. https://doi.org/10.1001/jamapsychiatry.2015.1858
- Heinrichs, N., & Hofmann, S. G. (2001). Information processing in social phobia: A critical review. Clinical Psychology Review, 21(5), 751–770.
- Hettema, J. M., Prescott, C. A., Myers, J. M., Neale, M. C., & Kendler, K. S. (2005). The structure of genetic and environmental risk factors for anxiety disorders in men and women. Archives of General Psychiatry, 62(2), 182–189. https://doi.org/10.1001/archpsyc.62.2.182
- Hoertel, N., Franco, S., Wall, M. M., Oquendo, M. A., Kerridge, B. T., Limosin, F., & Blanco, C. (2015). Mental disorders and risk of suicide attempt: A national prospective study. Molecular Psychiatry, 20(6), 718–726. https://doi.org/10.1038/mp.2015.19
- Horwood, L. J., Fergusson, D. M., Hayatbakhsh, M. R., Najman, J. M., Coffey, C., Patton, G. C., … Hutchinson, D. M. (2010). Cannabis use and educational achievement: Findings from three Australasian cohort studies. Drug and Alcohol Dependence, 110(3), 247–253. https://doi.org/10.1016/j.drugalcdep.2010.03.008
- Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617–627. https://doi.org/10.1001/archpsyc.62.6.617
- Kotov, R., Gamez, W., Schmidt, F., & Watson, D. (2010). Linking “big” personality traits to anxiety, depressive, and substance use disorders: A meta-analysis. Psychological Bulletin, 136(5), 768–821. https://doi.org/10.1037/a0020327
- Lev-Ran, S., & Feingold, D. (2017). Cannabis use and its association to mental illness: A focus on mood and anxiety disorders. In V. R. Preedy (Ed.), Handbook of cannabis and related pathologies ( 1st ed.). London, UK: Academic Press.
10.1016/B978-0-12-800756-3.00035-1 Google Scholar
- Lev-Ran, S., Imtiaz, S., Taylor, B. J., Shield, K. D., Rehm, J., & Le Foll, B. (2012). Gender differences in health-related quality of life among cannabis users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence, 123(1–3), 190–200. https://doi.org/10.1016/j.drugalcdep.2011.11.010
- Lev-Ran, S., Le Foll, B., McKenzie, K., George, T. P., & Rehm, J. (2013a). Bipolar disorder and co-occurring cannabis use disorders: Characteristics, co-morbidities and clinical correlates. Psychiatry Research, 209(3), 459–465. https://doi.org/10.1016/j.psychres.2012.12.014
- Lev-Ran, S., Le Foll, B., McKenzie, K., George, T. P., & Rehm, J. (2013b). Cannabis use and cannabis use disorders among individuals with mental illness. Comprehensive Psychiatry, 54(6), 589–598. https://doi.org/10.1016/j.comppsych.2012.12.021
- Lev-Ran, S., Le Foll, B., McKenzie, K., & Rehm, J. (2012). Cannabis use and mental health-related quality of life among individuals with anxiety disorders. Journal of Anxiety Disorders, 26(8), 799–810. https://doi.org/10.1016/j.janxdis.2012.07.002
- Linszen, D. H., Dingemans, P. M., & Lenior, M. E. (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry, 51(4), 273–279.
- Mackenzie, C. S., Reynolds, K., Cairney, J., Streiner, D. L., & Sareen, J. (2012). Disorder-specific mental health service use for mood and anxiety disorders: Associations with age, sex, and psychiatric comorbidity. Depression and Anxiety, 29(3), 234–242. https://doi.org/10.1002/da.20911
- Macleod, J., Oakes, R., Copello, A., Crome, I., Egger, M., Hickman, M., … Davey Smith, G. (2004). Psychological and social sequelae of cannabis and other illicit drug use by young people: A systematic review of longitudinal, general population studies. Lancet, 363(9421), 1579–1588. https://doi.org/10.1016/S0140-6736(04)16200-4
- Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet, 370(9584), 319–328. https://doi.org/10.1016/S0140-6736(07)61162-3
- Nanni, V., Uher, R., & Danese, A. (2012). Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: A meta-analysis. American Journal of Psychiatry, 169(2), 141–151. https://doi.org/10.1176/appi.ajp.2011.11020335
- National Academies of Sciences, Engineering, and Medicine. (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington, DC: National Academies Press.
- Olatunji, B. O., Cisler, J. M., & Tolin, D. F. (2007). Quality of life in the anxiety disorders: A meta-analytic review. Clinical Psychology Review, 27(5), 572–581. https://doi.org/10.1016/j.cpr.2007.01.015
- Penninx, B. W., Nolen, W. A., Lamers, F., Zitman, F. G., Smit, J. H., Spinhoven, P., … Beekman, A. T. (2011). Two-year course of depressive and anxiety disorders: Results from the Netherlands Study of Depression and Anxiety (NESDA). Journal of Affective Disorders, 133(1–2), 76–85. https://doi.org/10.1016/j.jad.2011.03.027
- Piccinelli, M., & Wilkinson, G. (2000). Gender differences in depression. British Journal of Psychiatry, 177, 486–492.
- Pull, C. B., Saunders, J. B., Mavreas, V., Cottler, L. B., Grant, B. F., Hasin, D. S., … Ustun, B. T. (1997). Concordance between ICD-10 alcohol and drug use disorder criteria and diagnoses as measured by the AUDADIS-ADR, CIDI and SCAN: Results of a cross-national study. Drug and Alcohol Dependence, 47(3), 207–216.
- Stetser, M., Shepherd, J., & Moore, T. F. (2002). Using the census 2000/2001 supplementary survey as a sampling frame for the national epidemiologic survey on alcohol and related conditions. Retrieved from https://www.amstat.org/sections/srms/proceedings/y2002/Files/JSM2002-000531.pdf
- Strakowski, S. M., DelBello, M. P., Fleck, D. E., Adler, C. M., Anthenelli, R. M., Keck, P. E., Jr., … Amicone, J. (2007). Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania. Archives of General Psychiatry, 64(1), 57–64. https://doi.org/10.1001/archpsyc.64.1.57
- Substance Abuse and Mental Health Services Administration. (2003). Results from the 2002 National Survey on Drug Use and Health: National findings. Rockville, MD: Office of Applied Studies.
- Sullivan, L. E., Fiellin, D. A., & O'Connor, P. G. (2005). The prevalence and impact of alcohol problems in major depression: A systematic review. American Journal of Medicine, 118(4), 330–341. https://doi.org/10.1016/j.amjmed.2005.01.007
- Suominen, K., Isometsa, E., Suokas, J., Haukka, J., Achte, K., & Lonnqvist, J. (2004). Completed suicide after a suicide attempt: A 37-year follow-up study. American Journal of Psychiatry, 161(3), 562–563. https://doi.org/10.1176/appi.ajp.161.3.562
- Swendsen, J. D., & Merikangas, K. R. (2000). The comorbidity of depression and substance use disorders. Clinical Psychology Review, 20(2), 173–189.
- Szuster, R. R., Pontius, E. B., & Campos, P. E. (1988). Marijuana sensitivity and panic anxiety. Journal of Clinical Psychiatry, 49(11), 427–429.
- Torres, A. R., Prince, M. J., Bebbington, P. E., Bhugra, D., Brugha, T. S., Farrell, M., … Singleton, N. (2006). Obsessive-compulsive disorder: Prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. American Journal of Psychiatry, 163(11), 1978–1985. https://doi.org/10.1176/ajp.2006.163.11.1978
- Twomey, C. D. (2017). Association of cannabis use with the development of elevated anxiety symptoms in the general population: A meta-analysis. [Review]. Journal of Epidemiology and Community Health, 71(8), 811–816. https://doi.org/10.1136/jech-2016-208145
- United Nations Office on Drugs and Crime. (2016). World drug report 2016. New York, NY: United Nations.
10.18356/603a2a94-en Google Scholar
- Volkow, N. D., Compton, W. M., & Weiss, S. R. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 371(9), 878–879. https://doi.org/10.1056/NEJMc1407928
- Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., … Baler, R. (2016). Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: A review. JAMA Psychiatry, 73(3), 292–297. https://doi.org/10.1001/jamapsychiatry.2015.3278
- Vrasti, R., Grant, B. F., Chatterji, S., Ustun, B. T., Mager, D., Olteanu, I., & Badoi, M. (1998). Reliability of the Romanian version of the alcohol module of the WHO Alcohol Use Disorder and Associated Disabilities: Interview Schedule –Alcohol/Drug-Revised. European Addiction Research, 4(4), 144–149.
- Walsh, K., Elliott, J. C., Shmulewitz, D., Aharonovich, E., Strous, R., Frisch, A., … Hasin, D. (2014). Trauma exposure, posttraumatic stress disorder and risk for alcohol, nicotine, and marijuana dependence in Israel. Comprehensive Psychiatry, 55(3), 621–630. https://doi.org/10.1016/j.comppsych.2013.11.016
- Ware, J., Jr., Kosinski, M., & Keller, S. D. (1996). A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220–233.
- Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., … Vos, T. (2013). Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. Lancet, 382(9904), 1575–1586. https://doi.org/10.1016/S0140-6736(13)61611-6
- Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., … Kleijnen, J. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. JAMA, 313(24), 2456–2473. https://doi.org/10.1001/jama.2015.6358
- WHO. (2016). The health and social effects of nonmedical cannabis use. Geneva, CH: WHO.
- Wittchen, H. U., Kessler, R. C., Zhao, S., & Abelson, J. (1995). Reliability and clinical validity of UM-CIDI DSM-III-R generalized anxiety disorder. Journal of Psychiatric Research, 29(2), 95–110.
- Wittchen, H. U., Zhao, S., Abelson, J. M., Abelson, J. L., & Kessler, R. C. (1996). Reliability and procedural validity of UM-CIDI DSM-III-R phobic disorders. Psychological Medicine, 26(6), 1169–1177.
- Woodward, L. J., & Fergusson, D. M. (2001). Life course outcomes of young people with anxiety disorders in adolescence. Journal of the American Academy of Child and Adolescent Psychiatry, 40(9), 1086–1093. https://doi.org/10.1097/00004583-200109000-00018
- Zhu, H., & Wu, L. T. (2016). Trends and correlates of cannabis-involved emergency department visits: 2004 to 2011. Journal of Addiction Medicine, 10(6), 429–436. https://doi.org/10.1097/ADM.0000000000000256
- Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982). Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects. Psychopharmacology, 76(3), 245–250.
- Zvolensky, M. J., Bernstein, A., Marshall, E. C., & Feldner, M. T. (2006). Panic attacks, panic disorder, and agoraphobia: Associations with substance use, abuse, and dependence. Current Psychiatry Reports, 8(4), 279–285.
- Zvolensky, M. J., Bernstein, A., Sachs-Ericsson, N., Schmidt, N. B., Buckner, J. D., & Bonn-Miller, M. O. (2006). Lifetime associations between cannabis, use, abuse, and dependence and panic attacks in a representative sample. Journal of Psychiatric Research, 40(6), 477–486. https://doi.org/10.1016/j.jpsychires.2005.09.005